INDUSTRIES
Life science
research park underway
university for NIH funding
annual research funding
at UC Davis
commercial lab space
$5 billion
ongoing annual
economic impact
Wexford Science + Technology
Aggie Square
UC Davis’ Aggie Square is a mixed-used innovation district focused on cell and gene therapy, genomics and imaging modalities. The research park is adjacent to the UC Davis Medical Center in Sacramento with plans for more than 1 million square feet of research, wet labs, commercial space and housing. Anchor tenants include Amazon Web Services, with announcements from additional market-leading companies forthcoming.
Wexford Science + Technology and GMH Capital Partners are overseeing the design, financing, construction and management of Phase I of Aggie Square. Wexford has extensive experience building research parks across the nation including University of Maryland BioPark in Baltimore and Downtown Crossing in New Haven.
BioSpace
BioSpace at The Bridge District is a 1.4 million square-foot Class A life science campus situated in West Sacramento’s waterfront mixed-use development near downtown Sacramento. Phase I includes a purpose-built lab of approximately 430,000 square feet.
The Port
The Port consists of 60 acres and 1.1 million square feet of dedicated manufacturing space. Strategically positioned just 2.5 miles from BioSpace at The Bridge District, located at the Port of West Sacramento, this facility offers a central location for life science endeavors. Tailored specifically for biomanufacturing, The Port serves as a pivotal resource for driving innovation and advancement in the field.
California Northstate University
California Northstate University is building a new, state-of-the-art medical center and teaching hospital in Sacramento. The $800 million, 1.22 million-sq.-ft. teaching hospital will feature a level II trauma center and offer intensive, acute, elective, and concierge medical care.
Life sciences success stories
Orca Bio
Biotech (cell therapy)
Orca Bio built a 100,000-square-foot commercial facility at Metro Air Park in Sacramento to support the late-stage clinical development and commercialization of its precision cell therapies.
Gemini Bio
Biotech
Gemini Bio is a leading manufacturer and supplier of cell culture media, sera and other reagents to academic researchers and the biotech, cell and gene therapy and biopharma industries. In 2020, the company established its state-of-the-art, 25,000-square-foot cGMP manufacturing facility in West Sacramento, quadrupling its manufacturing capacity.
ARIZ
Cancer research
ARIZ Precision Medicine is working to create a safer alternative to chemotherapy by developing a drug that targets cancer cells.
Penumbra
Medical devices
Penumbra designs, develops, manufactures and markets cutting-edge medical devices and has 250,000+ sq. ft. of office, research and design space in the region.
StemExpress
Biotech
Headquartered in Greater Sacramento and with cellular clinics across the country, StemExpress is a leading biospecimen provider for academic, biotechnological, diagnostic, pharmaceutical and contract research organizations.
Greater Sacramento Life Sciences Report
Greater Sacramento is seeing accelerated momentum, including in its life science industry. In 2023, Business Facilities ranked Sacramento #2 in the country for life science growth.
The region is the destination of California’s food and agriculture production, distribution, and innovation. It is home to leaders across the supply chain and UC Davis – the #1 university in the U.S. for both agriculture and forestry and veterinary medicine. Startups and global leaders in the agri-food tech and biotech industries come to the region for its talent, real estate, and quality of life.
Download a copy of the Greater Sacramento Life Sciences Report – a collaboration between Greater Sacramento Economic Council, Colliers, and CBRE – to learn more about the region’s trajectory and growth opportunities.
Looking for assistance? Contact our team today.
Contact our team to learn more about how we can help your company succeed.